Log In
Print this Print this

Reuptake inhibitors

  Manage Alerts
Collapse Summary General Information
Company Albany Molecular Research Inc.
DescriptionBiogenic amine reuptake inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
PartnerBristol-Myers Squibb Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today